Table 1 Comparion of clinical characteristics at entry in dyalisis indcution cohort studies
iDIC study | AICOPP | JSDT | USRDS | |
|---|---|---|---|---|
year | 2013–2015 | 2011–2013 | 2006 | 2013–2015 |
Number | 636 | 1524 | 9689 | 363,307 |
Dialysis modality (HD/PD/transplant) | 614/22/0 | 1409/105/0 | 8702/443/0 | 319,309/33,861/9325 |
Age (years old) | 67.4 ± 13.1 | 67.5 ± 13 | 66.6 ± 13.2 | 62.5 |
Gender (male/female) | 424/212 | 1032/492 | 6241/3448 | 210,785/152,522 |
Renal biopsy (%) | 12.8 | NA | N/A | NA |
Medical checkup history (%) | 40.3 | NA | NA | NA |
Diabetes at dialysis initiation (%) | 58.5 | 53.3 | 58.8 | NA |
Hypertension at dialysis initiation (%) | 93.8 | NA | NA | NA |
Prior myocardial infarction (%) | 9.6 | 15.8 | 8.0 | NA |
Prior stroke (%) | 15.5 | 13.7 | 15.0 | NA |
Prior peripheral artery disease (%) | 9.9 | 4.7 | NA | NA |
Prior malignancy (%) | 15.0 | 10.6 | 7.3 | NA |
Family history of kidney disease (%) | 10.3 | NA | NA | NA |
Primary kidney disease (%) | ||||
Diabetic nephropathy | 51.4 | 43.2 | 42.9 | 44.8 |
Hypertensive nephrosclerosis | 15.9 | 25.3 | 9.4 | 28.5 |
Chronic glomerulonephritis | 17.9 | 14.7 | 25.6 | 7.5 |
Autosomal dominant polycystic kidney disease | 2.5 | 3.3 | 2.4 | 2.2 |
Rapidly progressive glomerulonephritis | 2.5 | NA | 1.2 | NA |
Other disease | 6.0 | 13.5 | 8.6 | 17.0 |
Unknown cause | 3.8 | 9.9 | 2.4 | |
Body mass index (kg/m2) | 24.3 ± 4.5 | 23.5 ± 4.4 | NA | 29.6 |
Systolic blood pressure (mmHg) | 150.6 ± 26.5 | 151.1 ± 26.0 | 153 ± 28 | NA |
Diastolic blood pressure (mmHg) | 77.8 ± 16.3 | 77.1 ± 15.0 | 78 ± 16 | NA |
Hemoglobin (g/dL) | 9.0 ± 1.8 | 9.4 ± 1.5 | 8.4 ± 1.6 | 9.4 |
Serum creatinine (mg/dL) | 9.1 ± 2.9 | 9.0 ± 3.2 | 8.2 ± 3.3 | 6.4 |
Estimated glomerular filtration rate (mL/min/1.73m2) | 5.6 ± 1.8 | 5.6 ± 2.2 | 5.5 ± 3.3 | 9.8 |
Serum uric acid (mg/dL) | 8.5 ± 8.6 | 8.8 ± 2.4 | NA | NA |
Serum albumin (g/dL) | 3.5 ± 2.6 | 3.2 ± 0.6 | 3.3 ± 0.6 | 3.2 |
Serum total cholesterol (mg/dL) | 158.5 ± 48.0 | 162 ± 44.3 | NA | 155.5 |
Serum corrected calcium (mg/dL) | 8.5 ± 1.0 | 8.6 ± 1.1 | 8.6 ± 1.1 | NA |
Serum phosphate (mg/dL) | 6.2 ± 1.9 | 6.4 ± 1.9 | 5.8 ± 1.9 | NA |
Hemoglobin A1c (%) | 5.9 ± 0.9 | 5.8 ± 0.9 | NA | 6.7 |
Serum β2-microglobulin (mg/L) | 26.8 ± 52.5 | NA | NA | NA |
Intact-parathyroid hormone (pg/ml) | 289.5 ± 224.5 | 353 ± 292.4 | NA | NA |
Cumulative survival rate after 6 months (%) | 95.2% | NA | NA | NA |
Cumulative survival rate after 12 months (%) | 93.7% | NA | 87.4% | 80.8% |
Cumulative survival rate after 24 months (%) | 87.7% | NA | NA | 70.0% |